Funny..I think the independent third party valuation said RXMD was worth upto $2.20 a share, the price the board agreed upon.
Not to mention, all the vast majority of losses NXPL has recorded (most of which are non-cash) was due to RXMD...so perhaps RXMD isn't worth as much as you think it is.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.